CAS 1629615-23-1

Suptavumab

CAS: 1629615-23-1

Suptavumab (REGN2222) is a human antibody targeting subtypes A & B of RSV for research.

Reinheit: SDS-PAGE:96.3%;SEC-HPLC:99.2%

Farbe und Form: Liquid

Molekulargewicht: 146.04 kDa

Ref: TM-T76992

Suptavumab

CAS: 1629615-23-1

Humanized monoclonal antibody targeting the respiratory syncytial virus fusion protein

Ref: 3D-CLA1435